429 related articles for article (PubMed ID: 22934702)
1. Cell dormancy and tumor refractory.
Wang K; Jiang W; Cheng C; Li Y; Tu M
Anticancer Agents Med Chem; 2013 Feb; 13(2):1312-1316. PubMed ID: 22934702
[TBL] [Abstract][Full Text] [Related]
2. Tumor dormancy and cancer stem cells: two sides of the same coin?
Kleffel S; Schatton T
Adv Exp Med Biol; 2013; 734():145-79. PubMed ID: 23143979
[TBL] [Abstract][Full Text] [Related]
3. Metastatic Cell Dormancy and Re-activation: An Overview on Series of Molecular Events Critical for Cancer Relapse.
Muzes G; Sipos F
Anticancer Agents Med Chem; 2017; 17(4):472-482. PubMed ID: 27592547
[TBL] [Abstract][Full Text] [Related]
4. Dormancy and cancer stem cells: An enigma for cancer therapeutic targeting.
Talukdar S; Bhoopathi P; Emdad L; Das S; Sarkar D; Fisher PB
Adv Cancer Res; 2019; 141():43-84. PubMed ID: 30691685
[TBL] [Abstract][Full Text] [Related]
5. Cellular dormancy in minimal residual disease following targeted therapy.
Ruth JR; Pant DK; Pan TC; Seidel HE; Baksh SC; Keister BA; Singh R; Sterner CJ; Bakewell SJ; Moody SE; Belka GK; Chodosh LA
Breast Cancer Res; 2021 Jun; 23(1):63. PubMed ID: 34088357
[TBL] [Abstract][Full Text] [Related]
6. The epigenetic/noncoding origin of tumor dormancy.
Crea F; Nur Saidy NR; Collins CC; Wang Y
Trends Mol Med; 2015 Apr; 21(4):206-11. PubMed ID: 25771096
[TBL] [Abstract][Full Text] [Related]
7. Metastatic dormancy: a complex network between cancer stem cells and their microenvironment.
Bleau AM; Agliano A; Larzabal L; de Aberasturi AL; Calvo A
Histol Histopathol; 2014 Dec; 29(12):1499-510. PubMed ID: 24887025
[TBL] [Abstract][Full Text] [Related]
8. Disseminated Tumor Cells and Dormancy in Breast Cancer Progression.
Banys-Paluchowski M; Reinhardt F; Fehm T
Adv Exp Med Biol; 2020; 1220():35-43. PubMed ID: 32304078
[TBL] [Abstract][Full Text] [Related]
9. Dormant Cells: The Original Cause of Tumor Recurrence and Metastasis.
Li J; Jiang E; Wang X; Shangguan AJ; Zhang L; Yu Z
Cell Biochem Biophys; 2015 Jun; 72(2):317-20. PubMed ID: 25556072
[TBL] [Abstract][Full Text] [Related]
10. Tumor dormancy as an alternative step in the development of chemoresistance and metastasis - clinical implications.
Rossari F; Zucchinetti C; Buda G; Orciuolo E
Cell Oncol (Dordr); 2020 Apr; 43(2):155-176. PubMed ID: 31392521
[TBL] [Abstract][Full Text] [Related]
11. Tumor dormancy: long-term survival in a hostile environment.
Quesnel B
Adv Exp Med Biol; 2013; 734():181-200. PubMed ID: 23143980
[TBL] [Abstract][Full Text] [Related]
12. [Tumor dormancy and identification of therapeutic targets].
Li CF; Cao S; Meng SD
Ai Zheng; 2009 May; 28(5):555-8. PubMed ID: 19624889
[TBL] [Abstract][Full Text] [Related]
13. New clinical and experimental approaches for studying tumor dormancy: does tumor dormancy offer a therapeutic target?
Goss P; Allan AL; Rodenhiser DI; Foster PJ; Chambers AF
APMIS; 2008; 116(7-8):552-68. PubMed ID: 18834402
[TBL] [Abstract][Full Text] [Related]
14. Insights into the regulation of tumor dormancy by angiogenesis in experimental tumors.
Indraccolo S
Adv Exp Med Biol; 2013; 734():37-52. PubMed ID: 23143974
[TBL] [Abstract][Full Text] [Related]
15. Tumor dormancy of primary and secondary cancers.
Udagawa T
APMIS; 2008; 116(7-8):615-28. PubMed ID: 18834406
[TBL] [Abstract][Full Text] [Related]
16. Micrometastatic disease and metastatic outgrowth: clinical issues and experimental approaches.
McGowan PM; Kirstein JM; Chambers AF
Future Oncol; 2009 Sep; 5(7):1083-98. PubMed ID: 19792975
[TBL] [Abstract][Full Text] [Related]
17. EMT, CTCs and CSCs in tumor relapse and drug-resistance.
Mitra A; Mishra L; Li S
Oncotarget; 2015 May; 6(13):10697-711. PubMed ID: 25986923
[TBL] [Abstract][Full Text] [Related]
18. Label retaining cells in cancer--the dormant root of evil?
Schillert A; Trumpp A; Sprick MR
Cancer Lett; 2013 Nov; 341(1):73-9. PubMed ID: 23624300
[TBL] [Abstract][Full Text] [Related]
19. Cancer dormancy: a model of early dissemination and late cancer recurrence.
Páez D; Labonte MJ; Bohanes P; Zhang W; Benhanim L; Ning Y; Wakatsuki T; Loupakis F; Lenz HJ
Clin Cancer Res; 2012 Feb; 18(3):645-53. PubMed ID: 22156560
[TBL] [Abstract][Full Text] [Related]
20. Metastases in immune-mediated dormancy: a new opportunity for targeting cancer.
Romero I; Garrido F; Garcia-Lora AM
Cancer Res; 2014 Dec; 74(23):6750-7. PubMed ID: 25411345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
